October 16, 2012 — The American Institute of Ultrasound in Medicine (AIUM) will host an Ultrasound First Forum on Nov. 12, 2012, in New York City. The forum will address the expanding role of ultrasound imaging as a “first” imaging examination and will be devoted to encouraging the use of ultrasound as a safe, effective and affordable alternative to other diagnostic imaging modalities.

Three-year data from the Zilver PTX randomized controlled trial of paclitaxel-eluting stents for femoropopliteal disease from Cook Medical demonstrate 70.7 percent primary patency in the superficial femoral artery (SFA) at 36 months for patients treated with the paclitaxel-eluting stent.